Cargando…
N(6)-Methyladenosine regulator RBM15B acts as an independent prognostic biomarker and its clinical significance in uveal melanoma
Uveal melanoma (UM) is the most frequent intraocular malignant tumor in adults. N(6)-Methyladenosine (m(6)A) methylation is recognized as the most critical epigenetic change and is implicated in the development of many malignancies. However, its prognostic value in UM is poorly understood. RNA-seq a...
Autores principales: | Wang, Tianyu, Bai, Jianhao, Zhang, Yuanyuan, Xue, Yawen, Peng, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393712/ https://www.ncbi.nlm.nih.gov/pubmed/36003405 http://dx.doi.org/10.3389/fimmu.2022.918522 |
Ejemplares similares
-
MMP1 and MMP9 are potential prognostic biomarkers and targets for uveal melanoma
por: Wang, Tianyu, et al.
Publicado: (2021) -
BAP1 expression is prognostic in breast and uveal melanoma but not colon cancer and is highly positively correlated with RBM15B and USP19
por: Shahriyari, Leili, et al.
Publicado: (2019) -
Identification of Versican as an Independent Prognostic Factor in Uveal Melanoma
por: Xu, Jia, et al.
Publicado: (2021) -
Prognostic significance of deregulated microRNAs in uveal melanomas
por: Falzone, Luca, et al.
Publicado: (2019) -
N6-Methyladenosine Methylation Regulator RBM15 is a Potential Prognostic Biomarker and Promotes Cell Proliferation in Pancreatic Adenocarcinoma
por: Zhao, Zhiying, et al.
Publicado: (2022)